Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
clinical trials
life sciences
national blog main
ally bridge group
big data analytics
biotech ipos
blackrock
casdin capital
diabetic nephropathy
dyne therapeutics
eventide asset management
fda
focal segmental glomerulosclerosis
goldfinch bio
irving investors
jay ghosh
metacrine
myotonic dystrophy type 1
national top stories
nonalcoholic steatohepatitis
rare disease drugs
rare diseases
salk institute
san diego blog main
san diego top stories
schroeder adveq
software
third rock ventures
ulcerative colitis
wellington management company
yonjin capital
What
company
drug
genetic
ipo
2
×
medicines
2
×
million
raised
2
×
analysis
bio
biotech
bring
brings
develop
developing
diseases
disorders
dyne
dyne’s
employing
goldfinch
kidney
later
lead
muscle
muscular
new
preclinical
raises
rare
stage
studies
therapeutics
topped
upsized
Language
unset
Current search:
medicines
×
ipo
×
raised
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later